Parkinson’s Disease is a hypokinetic neurological disorder that leads to the degeneration of the substantia nigra pars compacta
so less dopamine is produced for the basal ganglia
πL-DOPA- synthetic dopamine
πRopinirole– D2 receptor agonist
πApomorphine– D1 and D2 receptor agonist
πAmantadine– blocks dopamine reuptake channel
πDomperidone– D2 antagonist (stops nausea and vomiting by preventing dopamine activating the chemoreceptor trigger zone.
π Selegiline + Entacopone– drugs that allow dopamine to remain
in high quantities in the CNS, without being further
converted to other products
πCarbidopa– dopa-decarboxylase inhibitor (prevents
dopamine leaving the CNS to the PNS)
OCD, PTSD, phobias, panic, social anxiety, generalised anxiety disorders
(due to increased glutaminergic activity (treat by increasing GABA activity)
Benzodiazepines (“-lam/-pam”)
4 Hours: Midazolam
15 Hours: lorazepam, oxazepam, temazepam
24 Hours: alprazolam, nitrazepam
48 Hours: chlordiazepoxide (lithium) diazepam (valium)
60 Hours: clonazepam, flurazepam
Side Effects: confusion, drowsiness, tolerance, dependence (tremor), respiratory depression with alcohol
(Flumazenil- used in BDZ overdose)
Buspirone- for general anxiety. (5HT agonist)
Barbiturates:
cause respiratory depression
Β
Sleep:
antihistamines (H1), nytol, valerenic acid (valarion extract)
chlormethiazole- for elderly as no hang-over effect
Insomnia: transient -> intermediate -> chronic
Z-drugs: (zzzz for sleep)
Zolpidem, zopiclone (REM deficiency)
General Anaesthetics enhance GABA (inhibitory = sleepy) receptors, apart from NOx which acts on NMDA (glutamate-R)
Local anaesthetics (“-caine”) work by blocking Na+ channels to stop pain action potentials
Amide Types:
Ester Types:
General Anaesthetics (“-caine”) (drug induced reversible loss of consciousness)
Β Inhaled- (maintain anaesthetic):
Huntington’s Disease occurs due to degeneration of the indirect pathway & overstimulation of dopamine receptors which cause hyperkinetic movement
Tetrabenazine- dopamine depletion (inhibit nigrostriatal pathway)
Restless leg – ropinirole (D2 agonist – desensitise to movement)
Tourettes – haloperidol (D2 antagonist)
Parasympathetic nervous system works on muscarinic (Ach) receptors
Muscarinic Agonist
Pilocarpine (used in glaucoma – increases trabecular outflow)
Muscarinic Antagonist
atropine
tropicamide
Β
To treat epilepsy, need to dampen neuronal hyperexcitability (reduce
excitation/ increase inhibitory influences)
Β Na+ channel blockers: carbamazepine, phenytoin, valproate, lamotrigine
Β Ca2+ channel blockers: ethosuximide, gapapentine
Β GABA breakdown inhibitors: valproate, vigabatrin (keeps GABA working to hyperpolarise cells)
Β GABAa modulator: benzodiazepines
Β NMDA antagonist: felbamate
Β AMPA antagonist: perampanel
Β Vesicle depletion: levetiracetam (reduce glutamate release)
Β GABA reuptake blocks: tiagabine (also used for anxiety)
Β
Characterised by:
Can be treated with:
π Tricyclic Antidepressants (TCAs):
Β
Β π Selective Serotonin Reuptake Inhibitors (SSRIs):
Β
π Selective Noradrenaline Reuptake Inhibitors (SNRIs):
Β
π Monoamine Oxidase Inhibitors (MAOIs):
Pain can either be
InflammatoryΒ pain
NSAIDS
Steroids (SAIDS)
Triptans
Β
Neuropathic Pain
Β
Opiates
Β
π naloxone- opiate antagonist (give for overdose)
Others:
Paracetamol. (in overdose, treat with activated charcoal in first
hour, then use acetylcysteine) (can lead to hepatotoxicity)
Schizophrenia- excess dopamine (so give dopamine antagonists). Leads to positive (auditory/visual hallucinations)Β and negative symptoms (withdrawal, lack of pleasure)
Β Typical Antipsychotics:
Atypical Antipsychotics: (first-line)
Aripiprazole: (third generation)
Neuropharm, NMJ, P450